Application of Stellera chamaejasme extract in preparing Mongolian medicine for treating prostatitis, mastitis and mumps
By using Mongolian medicine prepared by Ruixiang Wolverine Extract, the problem of insignificant efficacy in the treatment of prostatitis, mastitis and mumps in the prior art was solved, and rapid and effective treatment effects were achieved, especially for chronic prostatitis and mumps. significant improvement.
Patent Information
- Application Number
- CN202410132745.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-31
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-01-31
AI Technical Summary
The prior art has no significant efficacy in the treatment of prostatitis, mastitis and mumps, and the treatment time is long, especially the efficacy for chronic nonbacterial prostatitis, and conventional drugs have failed to show their advantages.
The Mongolian medicine is prepared by decoction, alcohol precipitation, ultrasonic extraction and other methods, as an effective ingredient for the treatment of prostate diseases, mastitis and mumps, combined with Carbomer, glycerol, hydroxyethyl ethyl esters and other substrates are prepared for gels, creams or powders.
It has achieved effective treatment for acute and chronic prostatitis, mumps and mastitis, with significant efficacy and short treatment time. The Rexiang Wolf Poison Mongolian medicine has anti-inflammatory, swelling and analgesic effects. The treatment course is only 5 days, and the cure rate is as high as more than 96%.
Smart Images

Figure CN117838751B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pharmaceuticals, in particular to application of a Stellera chamaejasme extract in preparing a Mongolian medicine for treating prostatitis, mastitis and mumps. Background Art
[0002] Prostate disease includes acute and chronic prostatitis and prostatic hyperplasia caused by chronic prostatitis. It is divided into bacterial (about 10%) and non-bacterial (about 90%), and is a common and frequently occurring disease in male urology. Prostatitis ranks first among male patients under 50 years old in urology; the incidence of chronic prostatitis in men over 35 years old is 35% to 40%. Clinically, symptoms such as frequent urination, painful urination, and dribbling urination may occur, and some may suffer from sexual dysfunction. The prevalence of prostatic hyperplasia in men aged 50 to 60 is as high as 50%, and the prevalence in men over 80 years old is as high as 100%. The main manifestations are increased nocturia, difficulty urinating, bladder stones, etc., and severe cases can also lead to hydronephrosis; the high incidence of prostate cancer between the ages of 75 and 80 is also related to chronic latent prostatitis in early years. About half (35%-50%) of men will be affected by prostatitis in their lifetime. [1] , the biggest problem for male compatriots is chronic prostatitis, and it is becoming more and more common. At present, although there are many treatment methods for prostatitis, drugs, external application of drugs and medical devices, dietary behavior, psychological induction, etc., are acceptable for types I to II, such as the highly recommended antibacterial drugs, saw palmetto fruit extract soft capsules and Pushitai, etc., and the course of treatment is in months. However, the effect of type III prostatitis (chronic non-bacterial, accounting for more than 90%) is not ideal, and the course of treatment is more than 6 months, the condition recurs repeatedly, and it is basically a lifelong companion. Therefore, chronic prostatitis still belongs to the category of difficult diseases. Similarly, the drugs in the prior art are not effective in treating mastitis and mumps, and the treatment time is relatively long. For a long time, traditional Chinese medicine and Mongolian medicine have been exploring treatment plans for prostatitis, mastitis and mumps, but the benefits of conventional medication are general and have not shown advantages. Summary of the invention
[0003] The purpose of the present invention is to provide an application of a Stellera chamaejasme extract in the preparation of a Mongolian medicine for treating prostatitis, mastitis and mumps, so as to solve the problems existing in the above-mentioned prior art. The Stellera chamaejasme extract of the present invention can effectively treat prostatitis, mastitis and mumps, and has the advantages of good efficacy and short treatment time.
[0004] To achieve the above object, the present invention provides the following solutions:
[0005] The invention provides application of a Stellera chamaejasme extract in preparing a Mongolian medicine for treating prostatitis, mastitis and mumps. The Stellera chamaejasme extract comprises a Stellera chamaejasme coumarin extract and / or a Stellera chamaejasme flavonoid extract.
[0006] Preferably, the preparation method of the coumarin extract of Stellera chamaejasme comprises the following steps:
[0007] The coumarin extract of Stellera chamaejasme was obtained by mixing Stellera chamaejasme and water in a mass ratio of 1:12, and then decocting with water and precipitating with alcohol.
[0008] Preferably, the degree of immersion is soaking; the time of water decoction is 60 minutes, and the number of times is 3 times; the solvent used for alcohol precipitation is 70% by volume ethanol solution.
[0009] Preferably, the preparation method of the Stellera chamaejasme flavonoid extract comprises the following steps:
[0010] The residue from which the coumarin of Stellera chamaejasme was extracted was mixed with an ethanol solution at a solid-liquid ratio of 1:20, and ultrasonic extraction and concentration were performed in sequence to obtain a flavonoid extract of Stellera chamaejasme.
[0011] Preferably, the ultrasonic extraction is performed for 120 minutes and twice; and the volume percentage of ethanol in the ethanol solution is 80%.
[0012] The invention provides a Mongolian medicine for treating prostatitis, mastitis and mumps. The effective components of the Mongolian medicine are coumarin extracts and / or flavonoid extracts of Stellera chamaejasme.
[0013] Preferably, when the active ingredient of the Mongolian medicine is the coumarin extract of Stellera chamaejasme, the mass percentage of the coumarin extract of Stellera chamaejasme in the Mongolian medicine is 10% to 15%;
[0014] When the active ingredient of the Mongolian medicine is the flavonoid extract of Stellera chamaejasme, the mass percentage of the flavonoid extract of Stellera chamaejasme in the Mongolian medicine is 0.05% to 0.20%;
[0015] When the effective ingredients of the Mongolian medicine are coumarin extracts from Stellera chamaejasme and flavonoid extracts from Stellera chamaejasme, the mass percentage of the coumarin extracts from Stellera chamaejasme in the Mongolian medicine is 10% to 15%, and the mass percentage of the flavonoid extracts from Stellera chamaejasme is 0.05% to 0.20%.
[0016] Further preferably, the Mongolian medicine is used by humans, that is, it is Mongolian medicine for humans.
[0017] Further preferably, when the subject of use is an animal, the content of the active ingredient in the Mongolian medicine is 10 times the content of the active ingredient in the Mongolian medicine for human use.
[0018] Further preferably, the preparation method of the coumarin extract of Stellera chamaejasme comprises the following steps:
[0019] The coumarin extract of Stellera chamaejasme was obtained by mixing Stellera chamaejasme and water in a mass ratio of 1:12, and then decocting with water and precipitating with alcohol.
[0020] Further preferably, the degree of immersion is soaking; the time of water decoction is 60 minutes, and the number of times is 3 times; the solvent used for alcohol precipitation is 70% by volume ethanol solution.
[0021] Further preferably, the preparation method of the Stellera chamaejasme flavonoid extract comprises the following steps:
[0022] The residue from which the coumarin of Stellera chamaejasme was extracted was mixed with an ethanol solution at a solid-liquid ratio of 1:20, and ultrasonic extraction and concentration were performed in sequence to obtain a flavonoid extract of Stellera chamaejasme.
[0023] Further preferably, the ultrasonic extraction is performed for 120 min and twice; and the volume percentage of ethanol in the ethanol solution is 80%.
[0024] Preferably, the Mongolian medicine further comprises a matrix; the matrix comprises one or more of carbomer, glycerol, triethanolamine, ethyl hydroxybenzoate, polysorbate, ethanol and medicinal starch.
[0025] Further preferably, the dosage form of the Mongolian medicine includes gel, cream or powder.
[0026] Preferably, when the dosage form of the Mongolian medicine is a gel, the preparation method of the Mongolian medicine comprises: mixing carbomer, glycerol and triethanolamine to obtain a transparent gel matrix; mixing the Stellera chamaejasme extract with ethyl hydroxybenzoate, polysorbate and ethanol to obtain an effective component solution; mixing the transparent gel matrix with the effective component solution to obtain the Mongolian medicine;
[0027] When the dosage form of the Mongolian medicine is an ointment, the preparation method of the Mongolian medicine comprises: mixing carbomer, glycerin and triethanolamine to obtain a transparent gel matrix; mixing the coumarin extract of Stellera chamaejasme with ethyl hydroxybenzoate and ethanol to obtain a solution containing the coumarin extract of Stellera chamaejasme; mixing the flavonoid extract of Stellera chamaejasme with polysorbate to obtain a solution containing the flavonoid extract of Stellera chamaejasme; mixing the transparent gel matrix with the solution containing the coumarin extract of Stellera chamaejasme and the solution containing the flavonoid extract of Stellera chamaejasme, grinding and emulsifying by co-grinding emulsification technology to obtain the Mongolian medicine;
[0028] When the dosage form of the Mongolian medicine is powder, the preparation method of the Mongolian medicine comprises: mixing the Stellera chamaejasme extract with medicinal starch to obtain the Mongolian medicine.
[0029] Preferably, when the dosage form of the Mongolian medicine is a gel, the mass volume ratio of the Stellera chamaejasme extract, carbomer, glycerol, triethanolamine, ethyl hydroxybenzoate, polysorbate and ethanol is 100-150g: 10g: 50g: 13g: 1g: 2g: 300mL, and more preferably 100g: 10g: 50g: 13g: 1g: 2g: 300mL;
[0030] When the dosage form of the Mongolian medicine is a cream, the mass volume ratio of the coumarin extract of Stellera chamaejasme, the flavonoid extract of Stellera chamaejasme, carbomer, glycerol, triethanolamine, ethyl hydroxybenzoate, polysorbate and ethanol is 100-150g: 0.5-2g: 10g: 50g: 13g: 1g: 2g: 300mL, and further preferably 100g: 0.5g: 10g: 50g: 13g; 1g: 2g: 300mL;
[0031] When the Mongolian medicine is in the form of powder, the mass ratio of the Stellera chamaejasme extract to the medicinal starch is 100-152:849.8, and more preferably 150.2:849.8.
[0032] The present invention discloses the following technical effects:
[0033] The extract of Stellera chamaejasme is applied externally (to the affected part or rectum) to effectively resist inflammation, reduce swelling and relieve pain; it has unique curative effect on acute and chronic prostatitis, prostatic hyperplasia, acute mumps and mastitis, and has the advantages of good curative effect and short treatment time. The treatment course of acute prostatitis is only 5 days, and 1 to 3 treatment courses can be cured; mumps can be cured by taking the medicine only 1 to 2 times, and the cure rate is as high as more than 96%; the curative effect on acute mastitis during lactation is also reliable.
[0034] According to the traditional theory and clinical practice of Mongolian medicine, the present invention extracts the effective anti-inflammatory and detumescent parts of Stellera chamaejasme, and develops a Mongolian medicine for external use, which is successful. The raw material resources of the Mongolian medicine are very rich, natural and green; the preparation and use are simple and scientific, the medication is safe, and the quality is controllable; the most important thing is that the efficacy is unique, the treatment course is as short as 5 days, and it is expected to bring unexpected recovery to hundreds of millions of prostate patients. At the same time, the Mongolian medicine provided by the present invention is different from the Mongolian medicine external prescription design and preparation method in the traditional method, and can provide different methods of use in combination with different groups of people.
[0035] In the preparation process, carbomer is selected as the base matrix, glycerin is added for moisturizing, triethanolamine is used to neutralize the pH value, and orderly processing is performed, which is the basis for the formation of the best gel matrix of the preparation; then, the Daphne chamaejasme extract, polysorbate, and ethylparaben with different solubilities are added to 50% (volume percentage) ethanol and co-dissolved at a certain temperature to achieve dissolution, solubilization, stabilization and preservation, which has become a unique technical integration of the present invention.
[0036] In the preparation of the preparation of the present invention, the extraction process technology route of the effective ingredients of Stellera chamaejasme is the prerequisite for the preparation to ensure the efficacy; the integrated technologies such as the detection and quality control of the extract, the reasonable design of the prescription, the orderly mixing and dissolution skills, and the optimization of the molding process parameters are the key technologies for the preparation (mainly the gel) to be qualified and exert its unique therapeutic effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0038] Figure 1 The chromatograms of the test analysis of the coumarin extract of Stellera chamaejasme are shown in Figure 1, wherein A is the HPLC graph of the mixed reference solution of aesculin + daphnetoside; and B is the HPLC graph of the test solution of the coumarin extract of Stellera chamaejasme;
[0039] Figure 2 The chromatograms of the test analysis of the flavonoid extract of Stellera chamaejasme, wherein A is the HPLC graph of the rutin reference solution; B is the HPLC graph of the test solution of the flavonoid extract of Stellera chamaejasme;
[0040] Figure 3 This is a line graph showing the effects of different active ingredients of Stellera chamaejasme on the rat swelling model;
[0041] Figure 4 The present invention provides a preparation process of Daphne koreana gel and Daphne koreana cream;
[0042] Figure 5 This is a curve diagram showing the effect of Daphne Gel B on the rat swelling model;
[0043] Figure 6 This is a bar graph showing the effects of Daphne Gel B on inflammatory factors and SOD in rat models. Among them, the differences between the different treatment groups and the model group were P < 0.05*, P < 0.01**. DETAILED DESCRIPTION
[0044] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0045] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0046] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0047] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0048] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0049] Stellera chamaejasme L. is a species listed in the Inner Mongolia Mongolian Medicinal Materials Standard (1021 Edition) and the Inner Mongolia Mongolian Medicinal Pieces Processing Specifications (2020 Edition). It is the dried root of Stellera chamaejasme L., a plant of the Thymelaeaceae family, and is a commonly used medicinal material exclusively for Mongolian medicine. It tastes bitter and pungent, is neutral in nature, and is toxic; it has the functions of killing "nien" (a term meaning pathogenic microorganisms), expelling diarrhea, eliminating "qiha" (a term meaning nodules), stopping decay, and reducing swelling. It is used for muscle, bone, and vein "qiha" diseases, erysipelas, mastitis, cheek swelling, "xie ri wusu" (a term meaning dampness) sores, and pox.
[0050] Example 1 Study on screening of active ingredients of raw material drug Stellera chamaejasme
[0051] 1. Extraction experiment
[0052] 1) Coumarin extracts from Stellera chamaejasme: Coumarin is a water-soluble effective part. According to the clinical experience of Mongolian medicine and literature reports, it was decided to use the decoction method for extraction. The extraction rate of aesculin was used as the observation index in this experiment. The main factors such as the material-liquid ratio, the decoction time and the number of decoction extractions were optimized. L9(34 ) The orthogonal test method was used for the test, as shown in Table 1 and Table 2 below.
[0053] Table 1 L9(3 4 ) Factor level table
[0054]
[0055] Table 2 Orthogonal experimental design and result analysis
[0056]
[0057] Take experiment 1 as an example to describe the extraction process: take the slices of Daphne Stellera chamaejasme, add appropriate amount of water and soak for 30 minutes, and complete the decoction extraction according to the experimental sequence number in Table 2 above, that is, experiment 1: add 12 times the amount of water (including the amount of water for soaking) and heat to a slight boil for 2 hours (120 minutes), filter; decoct the residue for 2 more times (3 times in total), combine the filtrate, concentrate until the filtrate just hangs on the wall of the bottle, take it out, cool to room temperature, add 70% (volume percentage) ethanol solution until the precipitation no longer increases, take the supernatant, concentrate, and dry below 60°C to obtain the coumarin extract. Experiment 2: add 12 times the amount of water (including the amount of water for soaking) and heat to a slight boil for 1.5 hours (90 minutes), filter; decoct the residue for 1 more time (2 times in total), combine the filtrate, (the same as experiment 1 below). Experiments 3 to 9 are analogous until experiment 9 is completed.
[0058] The test results recorded in Table 2 show that A1B1C1 is the best condition, and there is no significant difference between B1 and B3. Therefore, it is more reasonable to optimize to: A1B3C1, that is, add 12 times the amount of water, decoct for 60 minutes, and decoct 3 times.
[0059] At the same time, the alcohol precipitation process was examined to examine the effect of ethanol concentration on the content of coumarins such as aesculin and the effect of impurity precipitation. Specifically, 60%, 70% and 80% (volume percentage) ethanol solutions were selected for alcohol precipitation tests. The results showed that the 60% ethanol precipitation was turbid, difficult to filter, and the effect was not ideal; the 70% and 80% ethanol precipitations were ideal and easy to filter. The three alcohol precipitation methods had no significant effect on the content of aesculin, all of which were between 0.1973% and 0.2031%. For economic cost, 70% ethanol solution was selected. Therefore, the selection of 70% (volume percentage) ethanol is the best, which is in line with theory. Its addition amount is affected by the degree of concentration and has not been examined.
[0060] The extraction method of coumarin extracts from Stellera chamaejasme was finally determined as follows: take slices of Stellera chamaejasme, add 12 times the amount of water (weight to volume ratio) and soak until thoroughly soaked, heat to a slight boil for 1 hour, and filter; decoct the residue twice more, combine the filtrate, and concentrate until the filtrate just hangs on the wall of the bottle, take it out, cool it to room temperature, add 70% (volume percentage) ethanol solution until the precipitation no longer increases, take the supernatant, concentrate it, and dry it below 60°C to obtain a coumarin extract with a yield of 14%-18%. At the same time, high performance liquid chromatography was used to detect the coumarin extracts obtained, with scutellaria baicalensis and daphnetoclax as index reference substances. After analysis, it was determined to be a coumarin component ( Figure 1 ).
[0061] 2) Flavonoid extract of Stellera chamaejasme: Flavonoids are alcohol-soluble effective parts. According to theory and literature reports, most flavonoids such as rutin contained in Stellera chamaejasme are fully soluble in 80% (volume percentage) ethanol, so it was decided to extract with 80% ethanol first. This experiment used the rutin extraction rate as the observation index, and the residue of Stellera chamaejasme from which coumarin was extracted as the raw material. The main factors such as the material-liquid ratio, extraction time and extraction number were optimized. L9 (3 4 ) The orthogonal test method was used for the test, as shown in Table 3 below.
[0062] Table 3L9(3 4 )Orthogonal design experiment and result analysis
[0063]
[0064]
[0065] Take experiment 1 as an example to describe the extraction process: take the Daphne chamaejasme residue from which Daphne chamaejasme coumarins have been extracted in "1) Daphne chamaejasme coumarin extract", dry it naturally, weigh it, add an appropriate amount of water to soak it for 30 minutes, and complete the ultrasonic extraction according to the experimental sequence number in Table 3 above, that is, experiment 1: add 80% ethanol solution at a solid-liquid ratio of 1:20 (including the amount of soaking water), extract it by ultrasound (power 200W, frequency 40kHz) for 2h (120min), filter; repeat 2 more times (3 times in total), combine the alcohol solution, recover the ethanol, and concentrate to dryness to obtain the Daphne chamaejasme flavonoid extract. Experiment 2: add 80% ethanol solution at a solid-liquid ratio of 1:20 (including the amount of soaking water), extract it by ultrasound (power 200W, frequency 40kHz) for 1.5h (90min), filter; repeat 1 more time (2 times in total), combine the alcohol solution, and recover the ethanol (the same as experiment 1 below). Experiments 3 to 9 are analogous until experiment 9 is completed.
[0066] The test results showed that the conditions of experiment 1 were the best, and there was no significant difference between times 2 and 3. Therefore, the optimization was as follows: solid-liquid ratio 1:20, ethanol extraction time 120 min, and ethanol extraction 2 times.
[0067] The final extraction method of the flavonoid extract of Stellera chamaejasme was determined as follows: take the Stellera chamaejasme residue from which coumarins have been extracted in "1) Stellera chamaejasme coumarin extract", dry it naturally, weigh it, add 80% ethanol solution at a solid-liquid ratio of 1:20, extract it by ultrasonic (power 200W, frequency 40kHz) for 2h, and filter it; repeat once more, combine the alcohol solution, recover the ethanol, and concentrate it to dryness to obtain the flavonoid extract of Stellera chamaejasme. The yield is 5.0%-7.0% based on the original medicinal material. At the same time, the obtained Stellera chamaejasme flavonoid extract was detected by high performance liquid chromatography, with rutin as the index reference substance. After analysis, it was determined to be a flavonoid component ( Figure 2 ).
[0068] 3) The extraction method of terpenoid compounds of Stellera chamaejasme is as follows: the residue after extracting coumarin is dried in the sun, anhydrous methanol is added at a solid-liquid ratio of 1:10, reflux extraction is performed for 4 hours, repeated 3 times, the methanol solution is combined, and the methanol is recovered to about 1 / 10 of the volume of the combined methanol solution to obtain the primary extract, the primary extract, ethyl acetate and pure water are fully mixed at a mass volume ratio of 1g:3mL:3mL, magnetic stirring is performed for 20 minutes, the ethyl acetate layer is taken, and concentrated to dryness to obtain the terpene extract of Stellera chamaejasme. At the same time, an ultraviolet spectrophotometer is used for identification, and the reference substance is oleanolic acid, which is determined to be a terpene component.
[0069] 4) The extraction method of the lignan compound of Stellera chamaejasme is as follows: weigh the Stellera chamaejasme medicinal material, add 95% (volume percentage) ethanol at a solid-liquid ratio of 1:10, perform reflux extraction for 2h, repeat 2 times, and concentrate the combined extract to about 1 / 10 of the volume of the combined extract to obtain the primary extract. The primary extract, petroleum ether and pure water are fully mixed at a mass volume ratio of 1g:3mL:3mL, and magnetic stirring is performed for 20min. The petroleum ether layer is concentrated and dried to obtain the Stellera chamaejasme lignan extract. At the same time, the obtained Stellera chamaejasme lignan compound is detected by high performance liquid chromatography, and pinoresinol is used as an index reference. After analysis, it is determined to be a lignan compound.
[0070] 2. Pharmacodynamics study
[0071] 70 male SD rats weighing 190g-210g were randomly divided into a blank group (negative control), a model group, a control group (positive drug), a coumarin extract group of Stellera chamaejasme, a flavonoid extract group of Stellera chamaejasme, a terpenoid extract group of Stellera chamaejasme and a lignan extract group of Stellera chamaejasme after one week of adaptive feeding, with 10 rats in each group. Except for the model group, the blank group was given a blank matrix (fresh egg white), the control group was given dexamethasone ointment, and the Stellera chamaejasme coumarin extract group, Stellera chamaejasme flavonoid extract group, Stellera chamaejasme terpenoid extract group and Stellera chamaejasme lignan extract group were respectively given Stellera chamaejasme coumarin extract (A), Stellera chamaejasme flavonoid extract (B), Stellera chamaejasme terpenoid extract (C) and Stellera chamaejasme lignan extract (D). The single dose was calculated according to the extract content in 0.02g of the original medicinal material, and the egg white was used for application. The drug-treated group of experimental mice (fixed in a fixed frame) was smeared on the plantar of the right hind leg, wrapped with plastic wrap, and then fixed with medical gauze. The experimental mouse fixation frame was removed and kept for 8 hours, and then the gauze and plastic wrap were removed, and the application site was cleaned with water. The drug was administered once a day for 7 days; the model group was fixed in the same way, but no drug was applied. One hour after the last drug administration, 1% carrageenan was injected into the center of the plantar of the hind leg of each group of mice, with an injection volume of 100 μL / mouse. The foot swelling circumference was measured at 0.5h, 1h, 2h, 4h, 6h, 8h and 10h, and analyzed. The measurement results are shown in Table 4 and Figure 3 shown.
[0072] Table 4 Mean values of three-dimensional index detection data of rat swelling model (unit: mm)
[0073]
[0074]
[0075] Note: 0.5, 1…10h etc. in the table indicate the detection time points.
[0076] The results are shown in Table 4 and Figure 3 It can be seen from the records that the four extracts of Stellera chamaejasme, including coumarins, flavonoids, terpenes and lignans of Stellera chamaejasme, all showed different degrees of anti-inflammatory and detumescent effects. Among them, the flavonoids of Stellera chamaejasme were very significant (all p﹤0.05-0.01), and the antagonistic and detumescent effects were stable and lasting. Secondly, the detumescent effects of Stellera chamaejasme coumarins were significant in the late stage (p﹤0.05) and lasting, which was equivalent to positive drugs. The third was Stellera chamaejasme terpenes. The effect of Stellera chamaejasme lignans was not obvious, which may be related to its dose. It can be seen that Stellera chamaejasme flavonoids and Stellera chamaejasme coumarins have strong anti-inflammatory and detumescent effects; Stellera chamaejasme terpenes also have a certain effect but not as good as Stellera chamaejasme flavonoids and Stellera chamaejasme coumarins; Stellera chamaejasme lignans have a weak effect and a low content.
[0077] Example 2
[0078] Study on the preparation technology of Mongolian medicine for external use
[0079] 1) Basic requirements: The selected matrix should be stable in nature, have appropriate viscosity, be easily soluble in water, and be non-irritating to the skin and mucous membranes; it should have good solubility in the Mongolian medicine it contains, not produce chemical reactions, and not hinder the release of effective substances and mucous membrane absorption.
[0080] 2) Methods and implementation
[0081] Prescription 1 (Daphne gel A, preparation process as follows Figure 4 shown):
[0082] Components: Based on 1000 g, 100 g of the coumarin extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 10 g of carbomer, 50 g of glycerol, 13 g of triethanolamine, 1 g of ethylparaben, 2 g of polysorbate, 300 mL of 50% (volume percentage) ethanol and the remainder of pure water.
[0083] The preparation method is as follows: put carbomer in an appropriate amount of pure water to fully swell it, then add glycerol and stir; then take triethanolamine, slowly add it dropwise to the mixed solution containing carbomer and glycerol in a 70°C water bath, and stir to form a transparent gel matrix for later use; put the coumarin extract of Stellera chamaejasme, ethylparaben and polysorbate in a suitable container, add 300mL of 50% (volume percentage) ethanol, heat in a 50-60°C water bath to dissolve, mix with the gel matrix after complete dissolution, stir evenly, add pure water to the full amount, stir evenly, remove bubbles, and obtain Daphne Gel A.
[0084] Prescription 2 (Daphne gel B, preparation process as follows Figure 4 (shown)
[0085] Components: Based on 1000g, 100g of the coumarin extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 0.5g of the flavonoid extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 10g of carbomer, 50g of glycerol, 13g of triethanolamine, 1g of ethyl hydroxybenzoate, 2g of polysorbate, 300mL of 50% ethanol and the remainder of pure water.
[0086] The preparation method is as follows: put carbomer in an appropriate amount of distilled water to fully swell it, then add glycerol and stir; then take triethanolamine, slowly add it dropwise to the mixed solution containing carbomer and glycerol in a 70°C water bath, and stir to form a transparent gel matrix for later use; put coumarin extract of Stellera chamaejasme, flavonoid extract of Stellera chamaejasme, ethyl hydroxybenzoate, and polysorbate in a suitable container, add 300 mL of 50% (volume percentage) ethanol, heat in a 50-60°C water bath to dissolve, mix with the transparent gel matrix after complete dissolution, stir evenly, add pure water to the full amount, stir evenly, remove bubbles, and obtain Stellera chamaejasme Gel B.
[0087] Prescription 3 (Daphne koreana cream, preparation process as Figure 4 (shown)
[0088] Components: Based on 1000g, 100g of the coumarin extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 0.5g of the flavonoid extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 10g of carbomer, 50g of glycerol, 13g of triethanolamine, 1g of ethyl hydroxybenzoate, 2g of polysorbate, 300mL of 50% ethanol and the remainder of pure water.
[0089] First, grind the prescribed amount of flavonoid extracts from Stellera chamaejasme and dissolve them in polysorbate, then add a transparent gel matrix containing coumarin extracts from Stellera chamaejasme (the preparation method is the same as that of prescription 1), and grind and emulsify them using the co-grinding emulsification technology until everything is evenly mixed to obtain the Stellera chamaejasme ointment.
[0090] Prescription 4 (Daphne powder)
[0091] Components: Based on 1000 g, 150 g of the coumarin extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, 2 g of the flavonoid extract of Stellera chamaejasme prepared by the preparation method finally determined in Example 1, and the remainder of medicinal starch.
[0092] The preparation method is as follows: take the coumarin extracts from Stellera chamaejasme and the flavonoid extracts from Stellera chamaejasme, add medicinal starch to the full amount, mix well, and obtain the Stellera chamaejasme powder.
[0093] After the preparation of Daphne Gel A, Daphne Gel B and Daphne Gel Cream is completed, they are packaged as follows: the ointment is filled into a special syringe, each containing about 2 g, and the cap is put on, and sealed in a film plastic bag for rectal administration; or Daphne Gel B is sealed in a small plastic box, each containing 10 g, for external use to treat acute mumps or mastitis.
[0094] Daphne powder is packed in moisture-proof paper bags.
[0095] General requirements for drugs:
[0096] Specifications: Gels and creams are packaged in syringes, 2g / tube, or plastic bags, 10g / tube; powders: 10g / bag.
[0097] Dosage and Usage: For prostatitis, young and middle-aged people and those in the acute stage should use Daphne Gel B, or Daphne Gel A; the elderly and those with chronic hyperplastic sexually transmitted diseases should use Daphne Gel A; once a day, inject into the rectum 5-6cm after 1 hour of emptying, and keep for more than 4 hours; the course of treatment is 4-6 days. If necessary, take a 2-3 day break before the next course of treatment.
[0098] The boxed gel is used for mumps and mastitis. Apply it directly to the affected area twice a day until the swelling is significantly reduced. It usually takes 2-3 days to use.
[0099] For bagged powder, mix appropriate amount with egg white and apply to the affected area 1-2 times a day until the swelling is significantly reduced.
[0100] Note: ① This product should not be taken orally or accidentally put into the eyelids; ② It should not be used by those with strong rectal irritation; ③ It is forbidden for those who are allergic to this product; ④ Children are not allowed to apply the medicine on their own and must be supervised by an adult.
[0101] In the preparation of the preparation of the present invention, the extraction process technology route of the effective ingredients of Stellera chamaejasme is the prerequisite for the preparation to ensure the efficacy; the integrated technologies such as the detection and quality control of the extract, the reasonable design of the prescription, the orderly mixing and dissolution skills, and the optimization of the molding process parameters are the key technologies for the preparation (mainly the gel) to be qualified and exert its unique therapeutic effect.
[0102] Example 3
[0103] Related toxicology research information
[0104] Stellera chamaejasme is toxic and has laxative effect [3] According to literature reports: "The acute oral toxicity of the ethyl acetate extract of Stellera chamaejasme (mainly flavonoids) to mice is low (LD 50 >500mg / kg); acute skin irritation to white rabbits is non-irritating; eye irritation to white rabbits is mildly irritating (cornea and conjunctiva are slightly damaged, iris is not damaged. The highest acute eye irritation integral index (IOAO) is 7; the mean index of eye irritation (MIOI) of four levels after 1 to 72 hours is 1.0, 2.25, 1.5, 1.0, all within the mild irritation range of eye irritation classification in the national standard GB15670-1995)" [2] Its ointment (water-soluble extract mainly composed of coumarin) has a low LD500 for acute oral toxicity to mice. 50 894.4 mg / kg); single and multiple administrations to rabbits were non-irritating to the skin; 1 to 72 hours after instillation into the eyes of rabbits, there was slight damage to the conjunctiva, but no damage to the iris.[4] , indicating that the drug is safe and non-irritating for skin and rectal use; research by professionals has shown that multiple administrations of Stellera chamaejasme preparations (dissolved with egg white or vinegar) have no irritating reactions such as redness, swelling, and edema on the intact skin and damaged skin of rabbits; and no allergic reactions such as erythema and edema on guinea pigs. [5] .
[0105] The maximum dosage of the preparation provided by the present invention is designed as follows: 4.28 mg / kg of coumarin extract of Stellera chamaejasme (calculated as follows: medically, the average adult weight is 70 kg, the daily or one-time dosage is 2 g, and the dosage of 15% coumarin extract is 4.28 mg / kg (15%*2g / 70kg)); 0.058 mg / kg of flavonoid extract of Stellera chamaejasme (2%*2g / 70kg), which are far higher than the above LD 50 The value is low, less than 1% (the above LD 50 The value of 1 / 200 and 1 / 8000), not to mention the preparation of the present invention is a non-oral medication. Although rectal medication has a certain absorption rate and fast speed, and some drugs can directly enter the macrocirculation through the small veins under the rectum, the absorption rate is not high, the absorption area is limited, and most of the drugs diffuse to the surrounding tissues and lesions, and some are absorbed and retained by the lymphatic plexus. According to the rectal absorption theory, the rectal dosage should be twice the oral dosage. Therefore, the medication of the present invention is very safe, has no toxic side effects, and the slight foreign body sensation or irritation has a massage effect on the patient.
[0106] Example 4 Pharmacodynamics Study
[0107] Efficacy verification of Daphne Gel B (Stellera chamaejasme extract gel B prepared in Example 2):
[0108] 50 SD rats were randomly divided into 5 groups, namely, a blank group (negative control), a model group, a control group (positive), a medium dose group and a low dose group of the test drug, with 10 rats in each group. The administration method was the same as the "pharmacodynamic study" in Example 1. The test drug was Daphne Gel B, medium dose: 7.4% gel 1 mg / plantar, low dose: take 1 / 2 of the medium dose and add an equal amount of matrix, and administer 1 mg / plantar), induce inflammation and observe for 6 hours, detect the swelling dimension 5 times, and collect blood from the vein at the 6th hour to separate serum. Serological analysis was performed by Elisa to determine the changes in inflammatory factors such as IL-6, IL1-β, TNF-a and SOD activity in serum, and knee joint tissue was cut for analysis. The analysis results are shown in Tables 5-7 and Figure 5-6 .
[0109] Table 5 Effect of Daphne koreana gel on rat swelling model (unit: mm)
[0110] time 0.5 1 2 4 6 Compare p-value with model Efficacy Model Group 8.17 8.63 9.48 9.34 9.14 - Model success Low dose 7.60 8.05 9.02 8.99 8.56 Full time: ﹤0.05-0.01; 1h: 0.001 Non-significant Medium dose 7.85 7.95 8.93 9.16 8.62 The whole process is less than 0.05-0.01, the medium and low ratio is more than 0.05 Significant Negative group 7.68 8.18 9.20 9.43 8.86 Except for 0.5h, the whole process is >0.05 Comply with regulations Positive group 7.68 8.20 9.01 8.92 8.65 Full time ﹤0.05 Significant
[0111] The results are shown in Table 5 and Figure 5 As shown, the tested drugs showed relatively ideal anti-inflammatory and detumescent effects. Among them, the low-dose group had a very significant effect (all p﹤0.05-0.01, or 0.001), which was equivalent to the positive drug; the antagonistic and detumescent effects were stable and lasting. Secondly, the medium-dose group was significant (p﹤0.05-0.01), but not as good as the low-dose group, which may be due to the strong irritation of flavonoids in the effective part.
[0112] Table 6 Data table of the effect of Daphne Gel B on anti-inflammatory factors and SOD activity in rat models
[0113]
[0114] Table 7 Effects of Daphne Gel B on anti-inflammatory factors and SOD activity in rat swelling model
[0115]
[0116]
[0117]
[0118] From Table 6, Table 7 and Figure 6 It can be seen from the records that different doses of Daphne Gel B can affect the levels of inflammatory factors such as IL-6, IL1-β and TVF-α in rats to varying degrees, and increase the total SOD activity, which is more obvious in the low-dose group. This reflects that this dose has a significant antagonistic effect on inflammation. At 4h and 6h, compared with the model group, the p values of IL-6, IL1-β and SOD activity in the treatment groups of different doses of Daphne Gel B were all <0.05, the p values of IL1-β were all <0.01, and the p values of TVF-α were all <0.05 in the treatment groups of different doses of Daphne Gel B compared with the model group. The difference at the 6h test point was particularly significant.
[0119] Example 5
[0120] On May 10, 2023, Daphne Gel B (Stellera chamaejasme extract gel B prepared by the preparation method of Example 2, wherein the content of Stellera chamaejasme coumarin extract is 10%, and the content of Stellera chamaejasme flavonoid extract is 1%) was used to treat acute mastitis in dairy cows. The experimental site was Taigemu Town, Tumot Left Banner, Hohhot City. The experimental subjects were 10 cows suffering from acute mastitis. The dosage was 10 g / time, twice a day, and all were cured after 5 days of treatment, with satisfactory therapeutic effect.
[0121] Example 6
[0122] In the research of molding process, the selection of suitable matrix and the minimum amount as possible, no or minimal use of excipients, complete dissolution of drugs, good ointment or cream molding, and low local irritation to medication are all issues to be considered and solved.
[0123] 1. Select 9g of carbomer and add 90mL of water to completely swell as the matrix, add 1g of coumarin extract of Stellera chamaejasme, stir and dissolve; select 10mL of castor oil as the matrix and add 0.05g of flavonoid extract of Stellera chamaejasme to dissolve; the above two matrices are mixed and formed, and the viscosity and spreadability are both qualified. However, in human trials, local irritation is obvious, and rectal use causes diarrhea, so it failed;
[0124] 2. Same as the above process, select 9g of Carbomer and add 90mL of water to make it completely swollen as the matrix, add 1g of coumarin extract of Stellera chamaejasme, stir and dissolve; take an appropriate amount of glycerin (capable of dissolving the prescribed amount of flavonoids) and add the flavonoid extract of Stellera chamaejasme, heat to help dissolution; the two matrices are mixed again, the molding is acceptable, and the viscosity and spreadability are both qualified. However, it is unstable at room temperature. It will affect the quality of the medicine during the subsequent storage, so it is not suitable to use;
[0125] 3. In the example of step 2 above, adding an appropriate amount of polysorbate can increase stability, but long-term stability tests are required, so this method is temporarily abandoned;
[0126] 4. The preparations prepared by the above three molding processes "steps 1-3" showed mold growth and hair growth after being stored in the laboratory for more than one week at room temperature, so antiseptic measures should be taken. Therefore, an appropriate amount of preservative-triethanolamine (no mold infection will occur after packaging in the clean area) was added to the prescription; in addition, the pH value of the preparation is below 4 and should be adjusted to a value suitable for the rectum and skin mucosa. Therefore, an appropriate amount of ethylparaben was added to adjust the pH value to between 5 and 8 to reduce local discomfort;
[0127] 5. In the above four examples, although the preparation of the present invention can be formed, there is no problem under artificial preparation, and the application is basically safe and feasible. However, the dissolution of the flavonoid extract of Stellera chamaejasme is difficult, which is not conducive to large-scale production. Therefore, the use of 50% (volume percentage) ethanol solution as a solvent completely solves the drug dissolution problem of this preparation. That is: take carbomer and place it in an appropriate amount of distilled water to fully swell it; add glycerol and stir; then take triethanolamine and slowly add it dropwise to the mixed solution containing carbomer and glycerol in a 70°C water bath, and stir to make a transparent gel matrix for standby use. Separately, take coumarin extract of Stellera chamaejasme, flavonoid extract of Stellera chamaejasme, ethylparaben and polysorbate and place them in a suitable container, add 300 mL of 50% (volume percentage) ethanol solution, heat in a 50-60°C water bath to dissolve, mix with the gel matrix after complete dissolution, stir well, add distilled water to the full amount, stir well, remove bubbles, and this is called Stellera chamaejasme Gel B; the prescription lacking flavonoids is called Stellera chamaejasme Gel A.
[0128] Example 7 Clinical treatment trial results
[0129] This preparation was initially used in clinical trials to treat nearly 100 patients with chronic prostatitis, prostatic hyperplasia, mumps and acute mastitis, and the efficacy was satisfactory, showing a promising future. In order to further illustrate the efficacy of the preparation (Daphne gel B prepared in Example 2), the tested cases were grouped and summarized, and an analysis and statistics were made.
[0130] (1) Chronic prostatitis
[0131] Inclusion criteria: The patients were diagnosed with prostatitis by the chief physician of the Department of Urology of Inner Mongolia International Mongolian Medicine Hospital according to the current standards of the hospital, and the efficacy results were judged by the same physician.
[0132] Thirty middle-aged patients with chronic prostatitis were admitted, including 2 cases with cystitis.
[0133] Treatment plan: Use once a day, each dosage is 2g.
[0134] The subjective symptoms of frequent urination, urgency, pain when urinating and lower abdominal distension disappeared, and the pain and swelling during rectal examination were significantly improved.
[0135] Results: Among 30 middle-aged patients with chronic prostatitis, 27 showed marked effects, 2 improved, and 1 stopped taking the medicine; the total effective rate was over 97%, indicating that the prescription was indeed effective in treating prostatitis.
[0136] (2) Mumps
[0137] Inclusion criteria: Patients were diagnosed with infectious mumps by the chief physician of the Department of Pediatrics of Inner Mongolia International Mongolian Medicine Hospital according to the current standards of the hospital, and the efficacy results were judged by the same physician.
[0138] Fifteen cases of mumps were admitted, all of whom were children aged 8-15 years.
[0139] Treatment plan: Use twice a day, each time applying a very thin layer to fully cover the lump area.
[0140] Efficacy evaluation: swelling and pain disappeared.
[0141] Results: All patients were cured after 2-3 times of medication.
[0142] (3) Mastitis
[0143] Inclusion criteria: The patient was diagnosed with mastitis by the chief surgeon of the Inner Mongolia International Mongolian Medicine Hospital according to the current hospital standards, and the efficacy results were judged by the same physician.
[0144] Four cases of mastitis were admitted, all of them were young patients.
[0145] Treatment plan: Use twice a day, each time applying a very thin layer to fully cover the lump area.
[0146] Efficacy evaluation: Swelling and pain disappeared immediately.
[0147] Results: All patients were cured after 1-2 doses of medication.
[0148] Example 8 Quality Control Studies
[0149] The therapeutic effect of the preparation of the present invention is very significant, but there are certain side effects when the drug is used rectally, so the quality control of the drug and raw materials is extremely important. In the study, a relatively advanced and reliable quality control method was established.
[0150] In the identification item, the flavonoid extract of Stellera chamaejasme was effectively identified by ultraviolet and chemical reaction methods: 2g of Stellera chamaejasme flavonoid extract powder was taken, 10mL of ethanol was added, heated and refluxed for 10min, and filtered. The filtrate was applied on filter paper, sprayed with aluminum chloride test solution, dried, and observed under ultraviolet light (365nm), showing yellow-green fluorescence; 1mL of the filtrate was taken, 1mL of 2% sodium borohydride methanol solution was added, and allowed to stand for 1min, and then a few drops of hydrochloric acid were added, and allowed to stand again, showing red to purple. This indicates that it is a flavonoid compound.
[0151] In the content determination item, the high performance liquid chromatography method (General Chapter 0512 of the Chinese Pharmacopoeia (2020 Edition)) was first formulated for the coumarin extracts of Stellera chamaejasme, aesculin and chromone. The specific implementation is as follows:
[0152] 1. The chromatographic conditions and system suitability test of coumarin extracts from Stellera chamaejasme were carried out with octadecylsilane bonded silica gel as filler; methanol as mobile phase A and 0.2% phosphoric acid solution as mobile phase B, and gradient elution was performed according to the provisions in Table 8; the detection wavelength was 335 nm.
[0153] Table 8 Gradient elution
[0154] Time (min) Mobile phase A (%) Mobile phase B (%) 0 8 92 5 20 80 8 33 67 10 38 62 12 40 60 15 45 55 20 50 50 30 52 48 35 55 45 45 60 40
[0155] Preparation of reference solution: Take daphne (C 19 H 12 O6) and aesculin (C 15 H 16 O9) is added in an appropriate amount and 50% methanol is used to prepare a mixed reference solution containing 10 μg per 1 mL, wherein the concentration ratio of daphnetoclax to australonol in the mixed reference solution is 1:1, and the reference solution is obtained.
[0156] Preparation of test solution: Take about 5.0 g of coumarin extract powder from Stellera chamaejasme, accurately weigh it, put it in a stoppered conical flask, accurately add 60 mL of pure water, reflux extraction twice, each time for 60 min, combine the filtrate, precipitate with anhydrous ethanol, let it stand, take the supernatant, filter it, and obtain the solution.
[0157] Determination method: Accurately pipette 10 μl of reference solution and test solution respectively, inject into liquid chromatograph and determine.
[0158] 2. The chromatographic conditions and system suitability test of the flavonoid extract of Stellera chamaejasme were carried out, with octadecylsilane bonded silica gel as the filler; 0.1% phosphoric acid solution as the mobile phase A, acetonitrile as the mobile phase B, and gradient elution according to the provisions in Table 9; the detection wavelength was 335nm.
[0159] Table 9 Gradient elution
[0160]
[0161]
[0162] Preparation of reference solution: Take an appropriate amount of wolfsbane chromone reference substance and use 50% methanol to prepare a reference solution containing 100 μg per 1 mL to obtain the reference solution.
[0163] Preparation of the test solution: Take about 5.0 g of the powder of the flavonoid extract of Stellera chamaejasme, accurately weigh it, put it in a stoppered conical flask, accurately add 100 mL of 80% ethanol, extract it by ultrasonic twice, each time for 120 min, and combine the filtrate to obtain the test solution.
[0164] Determination method: Accurately pipette 10 μl of reference solution and test solution respectively, inject into liquid chromatograph and determine.
[0165] Content control standard: The extract is calculated based on the dry product. The coumarin extract of Stellera chamaejasme contains daphnetin (C 19 H 12O6) and aesculin (C 15 H 16 O9) shall not be less than 0.20%; the content of the flavonoid extract of Stellera chamaejasme shall not be less than 0.20%; the content of Stellera chamaejasme flavonoid extract ... 30 H 21 O9) shall not be less than 1.50%.
[0166] References
[0167] [1] Tikhomirova LI, markova LP, Tumbaa H. Coumarins from stellerachamaejasme L. [J]. Khim Prir Soedin, 1974, (3): 402.
[0168] [2] Kong Jie, Wu Jiajun, Shi Guanying et al., Preliminary study on the acute toxicity and activity of Stellera chamaejasme extract on experimental animals, Sichuan Animal Science, 2009, 28(2): 171.
[0169] [3] Mongolian Studies Encyclopedia Editorial Committee. Mongolian Studies Encyclopedia·Medical Volume, Inner Mongolia Publishing House, (Hohhot), 2022, 4: 962.
[0170] [4] Li Feng, Pei Le, Liu Xiuli, et al., Acute toxicity and skin irritation test of Stellera chamaejasme liniment, Animal Husbandry and Feed Science, 2018, 39(4): 5.
[0171] [5] Yang Moyin, Song Guangying. Experimental study on the skin irritation and sensitization of Xiaozhong Jiuwei Powder, Xiaozhong Jiuwei Powder (without Aconitum) and Stellera chamaejasme. Chinese Journal of Ethnomedicine, 2014, 11(11): 52.
[0172] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. The use of Stellera chamaejasme extract in the preparation of Mongolian medicine for treating chronic prostatitis, characterized in that: The Stellera chamaejasme extract comprises a Stellera chamaejasme coumarin extract and a Stellera chamaejasme flavonoid extract; The mass percentage of the coumarin extract of Stellera chamaejasme in the Mongolian medicine is 10% to 15%, and the mass percentage of the flavonoid extract of Stellera chamaejasme is 0.05% to 0.20%; The preparation method of the coumarin extract of Stellera chamaejasme comprises the following steps: The mixture is mixed with water in a mass ratio of 1:12, and then decocted in water and precipitated with alcohol to obtain a coumarin extract of Stellera chamaejasme; The degree of immersion is soaking; the time of water decoction is 60 minutes, the number of times is 3 times; the solvent used for alcohol precipitation is 70% by volume ethanol solution; The preparation method of the flavonoid extract of Stellera chamaejasme comprises the following steps: The residue from which the coumarin of Stellera chamaejasme has been extracted is mixed with an ethanol solution at a solid-liquid ratio of 1:20, and ultrasonic extraction and concentration are performed in sequence to obtain a Stellera chamaejasme flavonoid extract; The ultrasonic extraction time is 120 minutes and the number of times is 2 times; the volume percentage of ethanol in the ethanol solution is 80%.
2. A Mongolian medicine for treating chronic prostatitis, characterized in that: The effective ingredients of the Mongolian medicine are coumarin extracts from Stellera chamaejasme and flavonoid extracts from Stellera chamaejasme; the mass percentage of the coumarin extracts from Stellera chamaejasme in the Mongolian medicine is 10% to 15%, and the mass percentage of the flavonoid extracts from Stellera chamaejasme is 0.05% to 0.20%; The preparation method of the coumarin extract of Stellera chamaejasme comprises the following steps: The mixture is mixed with water in a mass ratio of 1:12, and then decocted in water and precipitated with alcohol to obtain a coumarin extract of Stellera chamaejasme; The degree of immersion is soaking; the time of water decoction is 60 minutes, the number of times is 3 times; the solvent used for alcohol precipitation is 70% by volume ethanol solution; The preparation method of the flavonoid extract of Stellera chamaejasme comprises the following steps: The residue from which the coumarin of Stellera chamaejasme has been extracted is mixed with an ethanol solution at a solid-liquid ratio of 1:20, and ultrasonic extraction and concentration are performed in sequence to obtain a Stellera chamaejasme flavonoid extract; The ultrasonic extraction time is 120 minutes and the number of times is 2 times; the volume percentage of ethanol in the ethanol solution is 80%.
3. The Mongolian medicine according to claim 2, characterized in that: The Mongolian medicine also includes a matrix; the matrix includes one or more of carbomer, glycerol, triethanolamine, ethyl hydroxybenzoate, polysorbate and ethanol.
4. The Mongolian medicine according to claim 3, characterized in that: When the dosage form of the Mongolian medicine is a gel, the preparation method of the Mongolian medicine comprises: mixing carbomer, glycerol and triethanolamine to obtain a transparent gel matrix; mixing the Stellera chamaejasme extract with ethyl hydroxybenzoate, polysorbate and ethanol to obtain an effective component solution; mixing the transparent gel matrix with the effective component solution to obtain the Mongolian medicine; When the dosage form of the Mongolian medicine is a cream, the preparation method of the Mongolian medicine includes: mixing carbomer, glycerin and triethanolamine to obtain a transparent gel matrix; mixing the coumarin extract of Stellera chamaejasme with ethylparaben and ethanol to obtain a solution containing the coumarin extract of Stellera chamaejasme; mixing the flavonoid extract of Stellera chamaejasme with polysorbate to obtain a solution containing the flavonoid extract of Stellera chamaejasme; mixing the transparent gel matrix with the solution containing the coumarin extract of Stellera chamaejasme and the solution containing the flavonoid extract of Stellera chamaejasme, grinding and emulsifying by using a co-grinding emulsification technology to obtain the Mongolian medicine.
5. The Mongolian medicine according to claim 4, characterized in that: When the dosage form of the Mongolian medicine is a gel, the mass volume ratio of the Stellera chamaejasme extract, carbomer, glycerol, triethanolamine, ethyl hydroxybenzoate, polysorbate and ethanol is 100-150 g: 10 g: 50 g: 13 g: 1 g: 2 g: 300 mL; When the dosage form of the Mongolian medicine is a cream, the mass volume ratio of the coumarin extract of Stellera chamaejasme, the flavonoid extract of Stellera chamaejasme, carbomer, glycerin, triethanolamine, ethyl hydroxybenzoate, polysorbate and ethanol is 100-150g:0.5-2g:10g:50g:13g:1g:2g:300mL.
